Science Explorer Back to mapMap
Discussion
Researcher · Progenics Pharmaceuticals (United States) · United States

Norbert Schülke

Norbert Schülke publishes mostly in Molecular Biology, Immunology and Virology, on topics such as HIV Research and Treatment, Mitochondrial Function and Pathology and Monoclonal and Polyclonal Antibodies Research.

OpenAlex
World rank
#1,466,083
of 7,710,434 ranked researchers
Rank in United States
#460,753
of 1,627,098
Works
17
Citations
1.3k
Citations per work
79.2
h-index
15
i10-index 15Top 50% in Molecular Biology
Norbert Schülke

What does Norbert Schülke research?

Norbert Schülke's work is mostly in Biochemistry, Genetics and Molecular Biology (33%), Immunology and Microbiology (26%), Medicine (14%).

Life Sciences: 10 works · 58.8% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 33.3% of their workMolecular Biology: 6 works · 33.3% of their workImmunology and Microbiology: 4 works · 25.5% of their workImmunology: 2 works · 13.7% of their workVirology: 2 works · 11.8% of their workEverything else: 4 works · 21.6% of their workHealth Sciences: 3 works · 19.6% of their workMedicine: 2 works · 13.7% of their workRadiology, Nuclear Medicine and Imaging: 2 works · 9.8% of their workEpidemiology: 1 works · 3.9% of their workNursing: 1 works · 5.9% of their workNutrition and Dietetics: 1 works · 5.9% of their workTHEIR WORKNorbert Schülke17works
Life Sciences59%Health Sciences20%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology633.3%
    2. Immunology and Microbiology425.5%
  2. Everything else421.6%
    1. Medicine213.7%
    2. Nursing15.9%
  1. 1Molecular Biology33% of their works
  2. 2Immunology14% of their works
  3. 3Virology12% of their works
  4. 4Radiology, Nuclear Medicine and Imaging10% of their works
  5. 5Nutrition and Dietetics6% of their works
  6. 6Epidemiology4% of their works

Research topics

Which keywords describe Norbert Schülke's research?

The keywords of their largest research topics: AIDS, Glycosylation, HIV, Mitochondria, Reactive Oxygen Species, Fc Receptors, Therapeutic Antibodies and Dendritic Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. AIDS61 topic
  2. Glycosylation62 topics
  3. HIV61 topic
  4. Mitochondria51 topic
  5. Reactive Oxygen Species51 topic
  6. Fc Receptors41 topic
  7. Therapeutic Antibodies41 topic
  8. Dendritic Cells31 topic
  9. Fructans31 topic
  10. Immunity31 topic
  11. Inulin31 topic
  12. NK Cell Recognition31 topic
  13. Natural Killer Cells31 topic
  14. Cancer21 topic
  15. Glycans21 topic
  16. Nitrogen21 topic
  17. Phosphorus21 topic

Where does Norbert Schülke work?

Norbert Schülke's main affiliation in the publication record is Progenics Pharmaceuticals (United States), United States.

How many publications and citations does Norbert Schülke have?

OpenAlex counts 17 works and 1,347 citations for Norbert Schülke, an h-index of 15, ranking #1,466,083 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Norbert Schülke. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.